Morisaki K - Search Results

1

Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.

Fetsch PA, Abati A, Litman T, Morisaki K, Honjo Y, Mittal K, Bates SE. Fetsch PA, et al. Among authors: morisaki k. Cancer Lett. 2006 Apr 8;235(1):84-92. doi: 10.1016/j.canlet.2005.04.024. Epub 2005 Jun 28. Cancer Lett. 2006. PMID: 15990223

2

Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.

Robey RW, Honjo Y, Morisaki K, Nadjem TA, Runge S, Risbood M, Poruchynsky MS, Bates SE. Robey RW, et al. Among authors: morisaki k. Br J Cancer. 2003 Nov 17;89(10):1971-8. doi: 10.1038/sj.bjc.6601370. Br J Cancer. 2003. PMID: 14612912 Free PMC article.

3

Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).

Honjo Y, Morisaki K, Huff LM, Robey RW, Hung J, Dean M, Bates SE. Honjo Y, et al. Among authors: morisaki k. Cancer Biol Ther. 2002 Nov-Dec;1(6):696-702. doi: 10.4161/cbt.322. Cancer Biol Ther. 2002. PMID: 12642696

4

Pheophorbide a is a specific probe for ABCG2 function and inhibition.

Robey RW, Steadman K, Polgar O, Morisaki K, Blayney M, Mistry P, Bates SE. Robey RW, et al. Among authors: morisaki k. Cancer Res. 2004 Feb 15;64(4):1242-6. doi: 10.1158/0008-5472.can-03-3298. Cancer Res. 2004. PMID: 14973080

5

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, Sarkadi B, Bates SE. Morisaki K, et al. Cancer Chemother Pharmacol. 2005 Aug;56(2):161-72. doi: 10.1007/s00280-004-0931-x. Epub 2005 Apr 19. Cancer Chemother Pharmacol. 2005. PMID: 15838659

6

Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.

To KK, Polgar O, Huff LM, Morisaki K, Bates SE. To KK, et al. Among authors: morisaki k. Mol Cancer Res. 2008 Jan;6(1):151-64. doi: 10.1158/1541-7786.MCR-07-0175. Mol Cancer Res. 2008. PMID: 18234970 Free PMC article.

7

The role of breast cancer resistance protein in acute lymphoblastic leukemia.

Plasschaert SL, van der Kolk DM, de Bont ES, Kamps WA, Morisaki K, Bates SE, Scheffer GL, Scheper RJ, Vellenga E, de Vries EG. Plasschaert SL, et al. Among authors: morisaki k. Clin Cancer Res. 2003 Nov 1;9(14):5171-7. Clin Cancer Res. 2003. PMID: 14613996

8

Mutational analysis of ABCG2: role of the GXXXG motif.

Polgar O, Robey RW, Morisaki K, Dean M, Michejda C, Sauna ZE, Ambudkar SV, Tarasova N, Bates SE. Polgar O, et al. Among authors: morisaki k. Biochemistry. 2004 Jul 27;43(29):9448-56. doi: 10.1021/bi0497953. Biochemistry. 2004. PMID: 15260487

9

Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

Polgar O, Ozvegy-Laczka C, Robey RW, Morisaki K, Okada M, Tamaki A, Koblos G, Elkind NB, Ward Y, Dean M, Sarkadi B, Bates SE. Polgar O, et al. Among authors: morisaki k. Biochemistry. 2006 Apr 25;45(16):5251-60. doi: 10.1021/bi0521590. Biochemistry. 2006. PMID: 16618113 Free PMC article.

10

Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas.

Kunishio K, Morisaki K, Matsumoto Y, Nagao S, Nishiyama Y. Kunishio K, et al. Among authors: morisaki k. Neurol Med Chir (Tokyo). 2003 Dec;43(12):573-80; discussion 581. doi: 10.2176/nmc.43.573. Neurol Med Chir (Tokyo). 2003. PMID: 14723263 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page